La chaîne d'options affiche les données clés des options sur actions de Orchestra BioMed Hldgs à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Orchestra BioMed Hldgs..

Orchestra BioMed Hldgs (NASDAQ:OBIO) Stock, Chaîne d'Options

ORCHESTRA BIOMED HOLDINGS IN

Orchestra BioMed Hldgs

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Orchestra BioMed Holdings, Inc. - Ordinary Shares

Orchestra BioMed Holdings Inc

News

Health Care

Press Releases

General

Orchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025

Vivasure Medical Submits PMA Application for PerQseal® Elite and Secures Expanded Venous Indication in Europe

Financing

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed

Orchestra BioMed Announces Proposed Public Offering

IPOs

Orchestra BioMed Announces Pricing of $40 Million Public Offering

Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings

Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility

Earnings

Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates

Orchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction

Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology

LGND

OBIO

Apyx Medical

Accuray

Anteris Technologies Global Corp. - Common Stock

Anteris Technologies Glb

Baird Medical Investment Holdings Ltd - Ordinary Share

Baird Medical Investment

BioSig Technologies

CapsoVision

CVRx

Electromed

Fonar

Hyperfine

Inogen

Kewaunee Scientific Corporation - Common Stock

Kewaunee Scientific

KORU Medical Systems, Inc. - Common Stock

KORU Medical Systems

LENSAR

Lucid Diagnostics

Pulmonx

Microbot Medical

Monogram Technologies Inc. - Common Stock

Monogram Technologies

Owlet

Pro-Dex

Profound Medical

Sight Sciences

Neuronetics

Vivani Medical

JIN MEDICAL INTERNATIONAL LTD. - Ordinary Shares

Jin Medical International

Chardan Capital

Barclays

HC Wainwright & Co.

B. Riley Securities

Jefferies

Comments

Orchestra BioMed Hldgs

Orchestra BioMed Hldgs (OBIO) Options

Orchestra BioMed Hldgs (NASDAQ:OBIO) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL